Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Finished Goods: 2022

Historic Finished Goods for Amylyx Pharmaceuticals (AMLX) over the last 1 years, with Dec 2022 value amounting to $937,000.

  • Amylyx Pharmaceuticals' Finished Goods was N/A to $937,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $937,000, marking a year-over-year change of. This contributed to the annual value of $937,000 for FY2022, which is N/A change from last year.
  • Per Amylyx Pharmaceuticals' latest filing, its Finished Goods stood at $937,000 for FY2022.
  • Amylyx Pharmaceuticals' Finished Goods' 5-year high stood at $937,000 during FY2022, with a 5-year trough of $937,000 in FY2022.
  • Moreover, its 1-year median value for Finished Goods was $937,000 (2022), whereas its average is $937,000.